A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

A randomized clinical trial was performed comparing recombinant follicle stimulating hormone (rFSH, Puregon, n = 54) and human menopausal gonadotrophin (HMG, Humegon, n = 35) in infertile women undergoing in-vitro fertilization without the use of a gonadotrophin-releasing hormone (GnRH) agonist. Mos...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human reproduction (Oxford) 1998-11, Vol.13 (11), p.2995-2999
Hauptverfasser:	Jansen, C A, van Os, H C, Out, H J, Coelingh Bennink, H J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Birth control Embryo Implantation Estradiol - blood Female Fertilization in Vitro Follicle Stimulating Hormone - therapeutic use Follicle Stimulating Hormone, Human Gynecology. Andrology. Obstetrics Humans Infertility, Female - therapy Luteinizing Hormone - blood Medical sciences Menotropins - therapeutic use Pregnancy Prospective Studies Recombinant Proteins - therapeutic use Sterility. Assisted procreation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!